Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Introduction to Urinary System01:13

Introduction to Urinary System

The urinary system consists of two kidneys, two ureters, the urinary bladder, and the urethra.
The kidneys are bean-shaped organs located in the retroperitoneal space, on either side of the vertebral column, between the T12 and L3 vertebrae. They are partially protected by the rib cage and surrounded by perirenal fat, which provides cushioning. They are responsible for urine formation and play critical roles in regulating blood pressure, electrolyte levels, and hormone production. The ureters...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunogenicity and reactogenicity of the adjuvanted respiratory syncytial virus vaccine in patients with chronic kidney disease.

Clinical kidney journal·2026
Same author

Positive net antiviral benefit of bexarotene against patient-derived archetype and rearranged BK polyomavirus isolates.

Antiviral research·2026
Same author

The Role of Cytomegalovirus-specific Immunoglobulins as Modulators of Antigen-specific T-cell Expansion In Vitro.

Transplantation direct·2025
Same author

Urinary Dickkopf-3 Predicts GFR Loss in the General Population.

Kidney international reports·2025
Same author

Dickkopf-3 (DKK3) and the Progression of Diabetic Kidney Disease in Primary Health Care.

Diabetes·2025
Same author

Cellular and humoral immunogenicity of respiratory syncytial virus vaccination in solid organ transplant recipients.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2025

Related Experiment Video

Updated: Jun 27, 2026

In Utero Intra-cardiac Tomato-lectin Injections on Mouse Embryos to Gauge Renal Blood Flow
10:25

In Utero Intra-cardiac Tomato-lectin Injections on Mouse Embryos to Gauge Renal Blood Flow

Published on: February 4, 2015

Erythropoietin and renoprotection.

Ferdinand H Bahlmann1, Danilo Fliser

  • 1Department of Internal Medicine IV, Saarland University Medical Centre, Homburg/Saar, Germany. ferdinand.bahlmann@uniklinikum-saarland.de

Current Opinion in Nephrology and Hypertension
|December 17, 2008
PubMed
Summary

Recombinant human erythropoietin (rHuEPO) offers significant tissue protection beyond correcting anemia, particularly in kidney injury. This review explores its non-hematological effects and potential renoprotective strategies.

More Related Videos

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
08:21

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

Related Experiment Videos

Last Updated: Jun 27, 2026

In Utero Intra-cardiac Tomato-lectin Injections on Mouse Embryos to Gauge Renal Blood Flow
10:25

In Utero Intra-cardiac Tomato-lectin Injections on Mouse Embryos to Gauge Renal Blood Flow

Published on: February 4, 2015

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
08:21

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

Area of Science:

  • Nephrology
  • Hematology
  • Pharmacology

Background:

  • Erythropoietin (EPO) primarily regulates red blood cell (RBC) production.
  • Recombinant human EPO (rHuEPO) is used to treat anemia in chronic kidney disease and cancer patients.
  • Emerging evidence suggests rHuEPO has non-hematological, tissue-protective effects.

Purpose of the Study:

  • To review the non-hematological effects of rHuEPO in experimental acute and chronic kidney injury.
  • To discuss the molecular pathways underlying rHuEPO's tissue-protective action, independent of anemia correction.
  • To examine clinical studies on rHuEPO and chronic kidney disease progression, proposing renoprotective strategies.

Main Methods:

  • Review of experimental studies on rHuEPO in various kidney injury models.
  • Analysis of literature on molecular mechanisms of rHuEPO's renoprotective effects.
  • Evaluation of clinical trial data concerning rHuEPO and chronic kidney disease.

Main Results:

  • rHuEPO demonstrates significant tissue-protective effects in experimental kidney injury models.
  • These protective effects are independent of rHuEPO's impact on anemia or tissue hypoxia.
  • Potential molecular pathways involved in rHuEPO's renoprotection are being elucidated.

Conclusions:

  • rHuEPO exhibits promising renoprotective properties beyond its erythropoietic function.
  • Further research into molecular pathways could lead to novel therapeutic strategies for kidney disease.
  • Clinical studies suggest potential benefits of rHuEPO in managing chronic kidney disease progression.